Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Nanoform Appoints Head of US Sales | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Nanoform Appoints Head of US Sales

Sally Langa to lead biz dev efforts across the U.S.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Nanoform, an innovative nanoparticle medicine enabling company, has appointed Sally Langa as head of U.S. sales. The new role will enable Nanoform to continue its growth with a strengthened presence in the U.S. market.
 
As head of U.S. sales, Ms. Langa will drive business development in this key region. Together with the rest of the commercial team, she will introduce and accelerate growth of Nanoform’s technology platform to major pharma and biotech companies in the U.S. market.
 
Ms. Langa has more than 30 years experience and a successful track record in senior business development positions in the field of formulations, tackling poorly soluble drugs. She has previously worked as vice president, global business development, development and analytical services for Catalent, and has also held other senior roles at Halo Pharmaceutical and Patheon.
 
The appointment comes at a time of growth for Nanoform, which recently filed for GMP status with the Finnish Medicines Agency, FIMEA. This increased manufacturing capability combined with the strengthening of its international commercial organization will enable the company to extend the reach of its award-winning nanonization technology.
 
“I am delighted to welcome Sally Langa to Nanoform,” said Edward Hæggström, chief executive officer, Nanoform. “The U.S. market is the largest in the world, and with this key appointment, we are now well positioned to build upon our current traction in this region.”
 
Christian Jones, chief commercial officer, said, “It is fantastic to have Sally join the commercial team. We have seen strong interest from the U.S. market and this appointment is key in driving further growth and ensuring our technology is as widely adopted as possible by our current and future partners. I look forward to working with a fellow professional with exceptional expertise in business development and in-depth knowledge of formulation enhancement.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters